Intervention

Biological samples collection

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting1

Common conditions7

Lead sponsors shown3

Clinical trials

3 shown

Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful BiomarkersNCT07259226 · 2025-11-14

RECRUITING

Establishment of the Human Intestinal and Salivary Microbiota Biobank - ObesityNCT04698135 · 2021-03-25

COMPLETED

Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis PatientsNCT02476084 · 2014-10-13

COMPLETED

Common conditions

Advanced Breast Cancer1 Advanced Gastric Cancer1 Advanced Non Small Cell Lung Cancer (NSCLC)1 Advanced Urothelial Cancer1 Metabolically Healthy Obesity1 Morbid Obesity1 Rheumatoid Arthritis1

Leading sponsors

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 1 UNICANCER 1 University of Oxford 1

Trial status mix

COMPLETED2

RECRUITING1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.